On Wednesday, April 3, 2019, the U.S. Food and Drug Administration (FDA) announced plans to hold a meeting to discuss its regulatory approach to products that contain cannabis and cannabis-derived compounds, including cannabidiol (CBD). The public hearing, which is scheduled to be held on May 31, 2019, is intended to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis and cannabis-derived compounds.

Husch Blackwell attorneys Seth Mailhot and Steve Levine issued a legal alert about this announcement. Find out what this means for the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis and cannabis-derived compounds.

Tags: CBD, FDA
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Seth Mailhot Seth Mailhot

With an education in chemical engineering and a prior career at the U.S. Food and Drug Administration, Seth brings clients rare regulatory insight on food, medical device and drug matters. As Leader of the firm’s FDA group, Seth handles a broad array…

With an education in chemical engineering and a prior career at the U.S. Food and Drug Administration, Seth brings clients rare regulatory insight on food, medical device and drug matters. As Leader of the firm’s FDA group, Seth handles a broad array of matters involving FDA-regulated products and services including food, medical devices, pharmaceuticals, biotechnology, tobacco, radiation-emitting electronic products and cosmetics.

Read more about Seth Mailhot
Show more Show less
Photo of Steve Levine Steve Levine

Steve is head of the firm’s Food Systems industry unit, Steve leads more than 45 professionals from numerous practice areas focused on the various food and agriculture industries. He excels in bringing creative, cost-effective solutions to the various challenges that our clients face.…

Steve is head of the firm’s Food Systems industry unit, Steve leads more than 45 professionals from numerous practice areas focused on the various food and agriculture industries. He excels in bringing creative, cost-effective solutions to the various challenges that our clients face.

Since 2009, Steve’s major focus has been on the burgeoning cannabis industry, where he guides clients through the tangle of shifting regulations governing the sale and use of cannabis in both the marijuana and industrial hemp sectors across the nation.

Read more about Steve LevineSteve's Linkedin Profile
Show more Show less
Related Posts
 Intoxicating Hemp in Wisconsin
October 16, 2024
 Minnesota Cannabis Update: What's Next?
June 24, 2024
 Schedule 3 Marijuana Alert: DEA Publishes NPRM
May 17, 2024